On Monday, Superior Energy Services, Inc. (NYSE:SPN)’s shares declined -2.00% to $16.66.
Superior Energy Services, Inc. (SPN) declared an adjusted net loss from ongoing operations for the second quarter of 2015 of $47.4 million, or a $0.31 loss per share, not taking into account special items, on revenue of $710.8 million. This compares to a net loss from ongoing operations of $1.5 million, or $0.01 loss per share for the first quarter of 2015, on revenue of $917.2 million. Stated loss from ongoing operations for the second quarter of 2015 was $775.1 million, or a $5.15 loss per share.
In light of the ongoing downturn in the oil and gas industry, counting the deteriorating demand for oilfield services, the Company stated a pre-tax charge of $807.6 million related to the reduction in value of assets during the second quarter of 2015. Of this charge, a pre-tax amount of $232.2 million related to the reduction in value of long-lived assets in the U.S. land and Mexico markets, primarily related to coiled tubing operations. The remaining amount, a pre-tax charge of $575.4 million, is an impairment of goodwill in the Company’s Production Services segment.
Superior Energy Services, Inc. provides specialized oilfield services and equipment to oil and gas companies in the United States, the Gulf of Mexico, and internationally. It operates through four segments: Drilling Products and Services; Onshore Completion and Workover Services; Production Services; and Technical Solutions. T
Bristol-Myers Squibb Co (NYSE:BMY)’s shares dropped -0.52% to $65.30.
Bristol-Myers Squibb Company (BMY) declared the establishment of the Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S. The I-O RPM program is a multi-institutional initiative with academic-based cancer centers focused on the clinical investigation of Immuno-Oncology therapeutics as potential treatment options for patients with high risk, poor prognostic cancers, defined as a rare population malignancy. A rare population malignancy is a subpopulation within a higher incident disease population (e.g. BRCA 1 and 2 breast cancer). These patients have aggressive disease with an raised potential for early metastasis to multiple sites and/or are initially refractory or subject to early recurrences with conventional cancer therapies.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
At the end of Monday s trade, Northstar Realty Finance Corp (NYSE:NRF)‘s shares surged 1.50% to $16.24.
NorthStar Realty Finance Corp. (NRF) declared that its Board of Directors has declared: (i) a quarterly cash dividend of $0.54688 per share of Series A preferred stock, (ii) a quarterly cash dividend of $0.51563 per share of Series B preferred stock, (iii) a quarterly cash dividend of $0.55469 per share of Series C preferred stock, (iv) a quarterly cash dividend of $0.53125 per share of Series D preferred stock, and (v) a quarterly cash dividend of $0.54688 per share of Series E preferred stock, in each case, payable on August 17, 2015 to shareholders of record on August 10, 2015.
Canadian Solar Inc. (NASDAQ:CSIQ), ended its Monday’s trading session with -7.84% loss, and closed at $24.75.
Canadian Solar Inc. (CSIQ), one of the world’s largest solar power companies, declared that the company is the supplier of 1.25 MW AC of 28 kW three-phase inverters to Renewable Solar Energy in central California. These inverters will be used in their three ground mount PV projects in Netto Farms, Tos Farms, and Summer Hill Dairy. Canadian Solar is also the supplier of 1.5 MW DC of Canadian Solar’s CS6X-305P solar panels. By offering inverters and PV panels together as part of a total system solution, this bundling allows Canadian Solar to further enhance their customer support services.
Canadian Solar Inc., together with its auxiliaries, designs, develops, manufactures, and sells solar wafers, cells, and solar power products worldwide. The company operates in two segments, Module and Energy. Its products comprise various solar modules that are used in residential, commercial, and industrial solar power generation systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
